Φορτώνει......

Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects

BACKGROUND: Gut microbiota-derived short-chain fatty acids (SCFAs) have been associated with beneficial metabolic effects. However, the direct effect of oral butyrate on metabolic parameters in humans has never been studied. In this first in men pilot study, we thus treated both lean and metabolic s...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:	Clin Transl Gastroenterol
Κύριοι συγγραφείς:	Bouter, KEC, Bakker, GJ, Levin, E., Hartstra, AV, Kootte, RS, Udayappan, SD, Katiraei, S., Bahler, L., Gilijamse, P. W., Tremaroli, V., Stahlman, M., Holleman, F., van Riel, N. A. W., Verberne, HJ, Romijn, JA, Dallinga-Thie, GM, Serlie, MJ, Ackermans, MT, Kemper, EM, Willems van Dijk, K., Backhed, F., Groen, AK, Nieuwdorp, M.
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Nature Publishing Group US 2018
Θέματα:	Article
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5968024/ https://ncbi.nlm.nih.gov/pubmed/29799027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41424-018-0025-4
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects

Παρόμοια τεκμήρια